View Clinical Trial (Medical Research Study)
Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section - NCT00694343-Lille - 004(Clinical Trial 225546)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Lille |
|
Country:
|
|
France |
|
|
|
| Conditions: |
|
Hypotension |
| Purpose: |
|
The aim of the study is to evaluate the efficacy of Voluven® in the prevention of maternal
hypotension in women undergoing spinal anesthesia for cesarean section
|
| Study summary: |
|
Intravenous fluid administration prior to spinal anesthesia for cesarean section is an
established part of anesthetic practice for the prevention of maternal hypotension.
Systematic reviews of clinical data suggest the usefulness of administering colloids to
decrease the incidence of hypotension This study will compare the clinical efficacy and
safety of HES 130/0.4 (6%) in normal saline vs. Ringer's lactate solution in prevention of
hypotension during spinal anesthesia for elective cesarean section. |
| Criteria: |
|
Inclusion Criteria:
- elective cesarean section applying spinal anesthesia
- ≥ week 37 of gestation
- Singleton pregnancy
Exclusion Criteria:
- Suspicion of any hypertensive disease
- Parturient in labor |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 1, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|